Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data
Background: Stevens-Johnson syndrome (SJS) has been reported as a serious adverse effect in patients treated with vancomycin or linezolid, and there is currently a lack of real-world studies comparing specific differences in adverse effects of SJS.Methods: According to the FDA’s Adverse Event Report...
Main Authors: | Ming Ni, Xue-Dong Yin, Wen-Juan Hu, Na Zeng, Bin Zhao, Zhi-Ling Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.872854/full |
Similar Items
-
Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
by: Olufemi Emmanuel Babalola
Published: (2020-12-01) -
Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
by: Gulseren Aktas
Published: (2020-07-01) -
Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid
by: M. V. Zhuravleva, et al.
Published: (2023-12-01) -
Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection
by: Szu-Ting Huang, et al.
Published: (2023-04-01) -
Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption
by: Flaminia Olearo, et al.
Published: (2021-02-01)